Heron Therapeutics Aktie
WKN DE: A1XB6K / ISIN: US4277461020
29.06.2020 15:57:31
|
Stock Alert: Heron Therapeutics Slips 30% Following FDA Letter
(RTTNews) - Shares of Heron Therapeutics, Inc. (HRTX) are falling more than 30% Monday morning after the biotechnology company announced that it received a Complete Response Letter from the FDA on June 26, 2020, regarding its New Drug Application for its drug candidate HTX-011, proposed for the management of postoperative pain.
The Complete Response Letter has requested additional non-clinical information. The FDA did not identify any clinical safety or efficacy issues or CMC issues, the company said in a statement.
Heron stock is currently trading at $13.62. It has traded in the range of $9.60- $26.81in the past 52 weeks.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Heron Therapeutics Incmehr Nachrichten
05.05.25 |
Ausblick: Heron Therapeutics stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
26.02.25 |
Ausblick: Heron Therapeutics vermeldet Zahlen zum jüngsten Quartal (finanzen.net) |
Analysen zu Heron Therapeutics Incmehr Analysen
Aktien in diesem Artikel
Heron Therapeutics Inc | 1,60 | -1,17% |
|